Bictegravir

Published February 21, 2018; Updated March 2018
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-04
Selected Reference
2. Sax PE, Pozniak A, Montes ML, et al. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet. 2017 Nov 4;390:2073-82.